14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 CTMX stock ended at $4.07. This is 6.86% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 10.32% from a day low at $4.07 to a day high of $4.49.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Mar 03, 2021 $8.41 $8.50 $8.02 $8.21 744 688
Mar 02, 2021 $8.39 $8.57 $8.13 $8.34 604 800
Mar 01, 2021 $8.02 $8.49 $7.96 $8.45 808 491
Feb 26, 2021 $7.86 $7.92 $7.53 $7.85 1 413 822
Feb 25, 2021 $8.13 $8.46 $7.83 $7.86 687 819
Feb 24, 2021 $8.01 $8.20 $7.80 $8.04 514 797
Feb 23, 2021 $8.03 $8.28 $7.75 $8.01 956 963
Feb 22, 2021 $8.76 $9.06 $8.48 $8.49 767 888
Feb 19, 2021 $8.71 $8.98 $8.66 $8.92 603 650
Feb 18, 2021 $8.44 $8.80 $8.23 $8.73 693 055
Feb 17, 2021 $8.65 $8.76 $8.23 $8.60 603 441
Feb 16, 2021 $9.42 $9.42 $8.59 $8.64 817 038
Feb 12, 2021 $8.26 $9.32 $8.05 $9.00 1 935 068
Feb 11, 2021 $8.60 $8.65 $8.12 $8.24 678 419
Feb 10, 2021 $8.80 $9.02 $8.33 $8.54 764 888
Feb 09, 2021 $8.87 $8.93 $8.54 $8.76 721 258
Feb 08, 2021 $8.25 $8.82 $8.05 $8.78 1 193 429
Feb 05, 2021 $7.70 $8.12 $7.62 $8.04 937 446
Feb 04, 2021 $7.58 $7.75 $7.34 $7.70 1 008 572
Feb 03, 2021 $7.75 $7.75 $7.43 $7.50 1 006 568
Feb 02, 2021 $7.56 $7.79 $7.36 $7.68 1 380 201
Feb 01, 2021 $7.25 $7.63 $7.06 $7.57 1 529 136
Jan 29, 2021 $7.01 $7.23 $6.82 $6.91 1 128 757
Jan 28, 2021 $7.09 $7.28 $6.92 $7.01 1 320 054
Jan 27, 2021 $7.03 $7.34 $6.77 $6.94 1 941 002
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT